A pivotal role for the natural interferon α-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus

Journal of Experimental Medicine

Volumn 194, Issue 12, 2001, Pages

  Rönnblom, Lars ^a   Alm, Gunnar V ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

AUTOIMMUNITY; DENDRITIC CELL; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; NOTE; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035905409     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.12.f59     Document Type: Note

References (38)

1. The function of type I interferons in antimicrobial immunity
2. IFN-α and IFN-β: A link between immune memory and chronic inflammation
3. Regulation of the IL-12/IL-12R axis: A critical step in T-helper cell differentiation and effector function
4. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
5. Interferon-α promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase
6. Human natural interferon-α producing cells
7. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-α inducer in systemic lupus erythematosus
8. Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells
9. The cell surface phenotype of human natural interferon-α producing cells as determined by flow cytometry
10. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand
11. Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin
12. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type 1 interferon
13. The nature of the principal type 1 interferon-producing cells in human blood
14. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization
15. Natural interferon-α/β-producing cells link innate and adaptive immunity
16. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12
17. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens
18. BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood
19. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction
20. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2
21. Autoimmunity after α-interferon therapy for malignant carcinoid tumors
22. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy
23. Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour
24. Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon
25. Serum interferon levels in patients with systemic lupus erythematosus
26. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-α- producing cells
27. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-α (IFN-α) production acting on leucocytes resembling immature dendritic cells
28. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-α inducer
29. Activation of natural interferon-α producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines
30. FCgammaRII (CD32)-dependent induction of interferon-α by serum from patients with lupus erythematosus
31. Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus
32. Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions
33. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus
34. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
35. An etiopathogenic role for the type I IFN system in SLE
36. Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: A candidate therapeutic for IDDM and SLE
37. Interferon expression in the pancreases of patients with type I diabetes
38. Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice